FDA approves new use for Roche’s Avastin in colon cancer treatment

(Reuters) – The U.S. Food and Drug Administration on Wednesday approved the use of Roche’s Avastin for patients whose colorectal cancer has worsened despite previous treatment with the drug. The new use will allow patients first treated with Avastin plus chemotherapy to be treated again with the biotechnology drug in combination with a different chemotherapy regimen. A pivotal clinical trial showed that such a treatment strategy improved survival. …

Changing food labels could boost understanding

NEW YORK (Reuters Health) – Alternative nutrition labels that clearly display the total number of calories and other nutrients in an entire package might help consumers make healthier food choices, according to a new study from the U.S. Food and Drug Administration. FDA researchers found people were best at assessing chips and frozen meals – and comparing the healthfulness of multiple products – when nutrition facts were presented for the entire container’s worth of food or for both one serving and the whole container. …

Drugmakers report U.S. shortages of flu vaccine, Tamiflu

Boston Mayor Thomas Menino addresses delegates during the second session of the Democratic National Convention in Charlotte(Reuters) – This year's U.S. flu season has created shortages of the Tamiflu treatment for children and of the most widely used flu vaccine, their manufacturers said. Roche Holding AG told Reuters late on Wednesday that it had a shortage of the liquid form of Tamiflu, given to children who already have the flu to slow or stop symptoms. A spokeswoman for the U.S. Food and Drug Administration confirmed that there have been supply interruptions in some locations. Roche said it told wholesalers and distributors in recent weeks that temporary delays in shipments were imminent. …

Teva questions safety of MS drug from rival Biogen

(Reuters) – Teva Pharmaceutical Industries Ltd, which makes the market-leading multiple sclerosis drug Copaxone, has filed a petition with the U.S. Food and Drug Administration that could, if granted, delay entry to the market of a rival drug developed by Biogen Idec Inc. Teva’s petition asks that the FDA not approve any new multiple sclerosis drug until its safety has been evaluated by a panel of outside advisors, and said it had uncovered “troubling information” on a publicly accessible website about the safety of Biogen’s drug, BG-12. …

New U.S. food safety rules by FDA seek more accountability

(Reuters) – U.S. regulators proposed new food safety rules on Friday that aim to make food processors and farms more accountable for reducing food borne illnesses that kill or sicken thousands of Americans annually. The rules, required by the Food Safety Modernization Act (FSMA) that was signed into law two years ago, were announced by the U.S. Food and Drug Administration on Friday. The agency has come under heavy criticism for failing to introduce new food safety rules faster, but many of those critics applauded FDA’s announcement. …

1 2 3 18